Loren Data's SAM Daily™

FBO DAILY - FEDBIZOPPS ISSUE OF AUGUST 29, 2018 FBO #6123
SOLICITATION NOTICE

65 -- Botulinum Toxin ELISA Kits - RFQ

Notice Date

8/27/2018
 

Notice Type

Combined Synopsis/Solicitation
 

NAICS

325413 — In-Vitro Diagnostic Substance Manufacturing
 

Contracting Office

Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services - Philadelphia, 200 Chestnut Street, Room 900, Philadelphia, Pennsylvania, 19106, United States
 

ZIP Code

19106
 

Solicitation Number

18-223-SOL-1201361
 

Archive Date

9/7/2018
 

Point of Contact

Janice Heard, Phone: 215-717-3093
 

E-Mail Address

janice.heard@fda.hhs.gov
(janice.heard@fda.hhs.gov)
 

Small Business Set-Aside

N/A
 

Description

RFQ for Botulinum Toxin ELISA Kits The Food and Drug Administration intends to award a contract for Botulinum Toxin EISA Kits. The solicitation number is, 18-223-SOL-1201361. This solicitation is issued as a Request for Quote (RFQ). A source's sought announcement was published under #1201361. All responsible sources may submit a quote which shall be considered. The requirement is competed unrestricted and made available to Full and Open competition, meaning any qualified vendor regardless of size status may submit a quote. The associated North American Industry Classification System (NAICS) Code is 325413. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR part 12, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals/bids are being requested and a written solicitation will not be issued. The solicitation document is attached and incorporates provisions and clauses in effect through Federal Acquisition Circular (FAC) 2005-100, August 22, 2018. The Defense Priorities and Allocations System and assigned rating are not applicable to this solicitation notice. An official authorized to bind the Offeror must sign the terms and conditions of the offer. Offerors that fail to finish required representations, or reject the terms and conditions of the solicitation, may be excluded from consideration. The Government is not responsible for locating or securing any information, which is not identified in the submission. To ensure sufficient information is available, vendors must furnish as part of their proposal all descriptive material (such as cuts, illustration, drawings, or other information) necessary for the Government to determine whether the product meets their requirements. All offers are due in person, by mail, e-mail on or before September 6, 2018 by 1:00 pm (Eastern Time), at Food and Drug Administration, U.S. Customhouse, 200 Chestnut Street, Philadelphia, PA 19106, Attn: Janice Heard. ph (215)717-3093, fax (215)597-4390, email: Janice.Heard@fda.hhs.gov.
 

Web Link

FBO.gov Permalink
(https://www.fbo.gov/notices/71ff30c778d9d0af24f256888ba2acd0)
 

Place of Performance

Address: 8301 Muirkirk Road, LAUREL, Maryland, 20708, United States

Zip Code: 20708
 

Record

SN05057670-W 20180829/180827231138-71ff30c778d9d0af24f256888ba2acd0 (fbodaily.com)
 

Source

FedBizOpps Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |